A simple, rapid, and reliable method for simultaneous assay of losartan, its active metabolite E-3174, and glibenclamide was developed and validated. The method is universal and allows metabolites to be assayed in both serum and urea. Application of the method for determination of the activity of isoenzyme CYP2C9 with simultaneous monitoring of glibenclamide conditions was demonstrated. The method was shown to be specific for assay of study compounds in patients simultaneously taking multiple drugs.
Similar content being viewed by others
References
M. Zoppi, S. Braunschweig, U. P. Kuenzi, et al., Eur. J. Clin. Pharmacol., 56(5), 427 – 430 (2000).
J. Kirchheiner, J. Brockmöller, I. Meineke, et al., Clin. Pharmacol. Ther., 71(4), 286 – 296 (2002).
A. Surendiran, S. C. Pradhan, A. Agrawal, et al., Eur. J. Clin. Pharmacol., 67(8), 797 – 801 (2011).
Z. Li, G. Wang, L. S. Wang, et al., Xenobiotica, 39(10), 788 – 793 (2009).
A. Petsalo, M. Turpeinen, O. Pelkonen, et al., J. Chromatogr. A, 1215(1 – 2), 107 – 115 (2008).
P. Dorado, E. Machín, F. de Andrés, et al., Drug Metab. Drug Interact., 27(4), 217 – 223 (2012).
F. De Andrés, M. Sosa-Macías, and A. Lerena, Bioanalysis, 6(5), 683 – 696 (2014).
Ü. Yasar, C. Forslund-Bergengren, G. Tybring, et al., Clin. Pharmacol. Ther., 71(1), 89 – 98 (2002).
S. Tanaka, S. Uchida, N. Inui, et al., Biol. Pharm. Bull., 37(1), 18 – 25 (2014).
G. Sartor, A. Melander, B. Schersten, et al., Diabetologia, 18(1), 17–22 (1980).
L. A. Sánchez-Nava, U. Bautista-Sánchez, A. L. Robles-Piedras, GSC Biol. Pharmaceut. Sci., 7(01), 96 – 101 (2019).
G. I. Gorodetskaya, E. V. Shikh, M. V. Zhuravleva, et al., Ved. Nauchn. Tsentr. Éksper. Sredstv. Med. Primen., 7(4), 199 – 211 (2017).
I. E. Shokhin, G. V. Ramenskaya, G. F. Vasilenko, et al., Vopr. Biol. Med. Farm. Khim., 7(6), 36 – 38 (2009).
C. Hess, F. Musshoff, and B. Madea, Anal. Bioanal. Chem., 400(1), 33 – 41 (2011).
K. S. Lakshmi and T. Rajesh, ISRN Pharmaceutics, 2011 (2011).
T. M. Binz, N. Villani, H. Neels, et al., Forensic Sci. Int., 223(1–3), 119 – 124 (2012).
X. Zhang, X. Wang, D. I. Vernikovskaya, et al., Biomed. Chromatogr., 29(4), 560 – 569 (2015).
H. J. Shah, M. L. Kundlik, N. K. Patel, et al., J. Sep. Sci., 32(20), 3388 – 3394 (2009).
B. Prasaja, L. Sasongko, Y. Harahap, et al., J. Pharmaceut. Biomed., 49(3), 862 – 867 (2009).
M. Polinko, K. Riffel, H. Song, et al., J. Pharmaceut. Biomed., 33(1), 73 – 84 (2003).
T. Iwasa, T. Takano, K. I. Hara, et al., J. Chromatogr. B, 734(2), 325 – 330 (1999).
R. A. Stearns, P. K. Chakravarty, R. Chen, et al., Drug Metab. Dispos., 23(2), 207 – 215 (1995).
P. A. Shah, P. Sharma, J. V. Shah, et al., Turk. J. Chem., 39(4), 714 – 733 (2015).
C. Krämer, J. Sunkomat, J. Witte, et al., Circ. Res., 90(7), 770 – 776 (2002).
C. I. Furtek and M. W. Lo, J. Chromatogr. B, 573(2), 295 – 301 (1992).
T. Rydberg, A. Jönsson, and A. Melander, J. Clin. Pharm. Ther., 20(5), 283 – 295 (1995).
I. Niopas and A. C. Daftsios, J. Pharmaceut. Biomed., 28(3–4), 653 – 657 (2002).
A. N. Mironov (ed.), Guidelines for Expert Assessment of Medicines [in Russian], Grif i. K, Moscow (2013), Vol. 1, pp. 201 – 207.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 1, pp. 52 – 59, January, 2022.
Rights and permissions
About this article
Cite this article
Gorodetskaya, G.I., Bunyatyan, N.D., Mel’nikov, E.S. et al. A Method for Assay of Losartan, Its Active Metabolite E-3174, and Glibenclamide in Human Serum and Urine by HPLC-MS/MS. Pharm Chem J 56, 118–125 (2022). https://doi.org/10.1007/s11094-022-02612-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-022-02612-3